Evolent Health Inc Stock News

Evolent Health, Inc with ticker code (EVH) have now 5 analysts in total covering the stock. The consensus rating is ''Strong_Buy''. The target price ranges between 44 and 35 and has a mean target at 38.4. Now with the previous closing price of 23.32 this would imply there is a potential upside of 64.7%. The 50 day moving average now sits at 25.17 and the 200 day MA is 24.61. The company has a market capitalisation of $2,187m. Find out more information at: https://www.evolenthealth.com [stock_market_widget type="chart" symbol="EVH" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $3,601m based on the market concensus. Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

WASHINGTON, Dec. 14, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today

Harel Insurance Investments & Financial Services Ltd. lessened its stake in Evolent Health, Inc. (NYSE:EVH) by 33.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,058 shares of the technology companys stock after selling 2,523 shares during the quarter. Harel []

Royal Bank of Canada boosted its position in Evolent Health, Inc. (NYSE:EVH) by 12.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,905 shares of the technology companys stock after acquiring an additional 2,051 shares during the quarter. Royal Bank of Canadas holdings []

Prudential Financial Inc. decreased its holdings in shares of Evolent Health, Inc. (NYSE:EVH) by 6.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,052 shares of the technology companys stock after selling 766 shares during the period. Prudential Financial []

Genesee Capital Advisors LLC bought a new position in shares of Evolent Health, Inc. (NYSE:EVH) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 105,503 shares of the technology companys stock, valued at approximately $3,271,000. Evolent Health makes up approximately 1.6% of Genesee Capital Advisors []

Cubist Systematic Strategies LLC lifted its stake in shares of Evolent Health, Inc. (NYSE:EVH) by 45.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,661 shares of the technology companys stock after acquiring an additional 7,400 shares during the []

JPMorgan Chase & Co. upgraded shares of Evolent Health (NYSE:EVH) from a neutral rating to an overweight rating in a research report report published on Thursday, Analyst Ratings Network reports. JPMorgan Chase & Co. currently has $37.00 price target on the technology companys stock, up from their prior price target of $26.00. Several other equities []

Evolent Health, Inc. (NYSE:EVH)s stock price gapped up before the market opened on Thursday . The stock had previously closed at $27.79, but opened at $29.37. Evolent Health shares last traded at $29.43, with a volume of 16,461 shares changing hands. A number of analysts have recently weighed in on EVH shares. TheStreet upgraded Evolent []

Related Stocks: EVH , TLMD , CMAX , EA , CHRS , EXC , GDP , TBT , OAS , CANO , MARA ,

DUBLIN--(BUSINESS WIRE)--The "Sawmills and Wood Preservation Plants Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 321100" report from Plunkett Research Ltd has been added to ResearchAndMarkets.com''s offering. This report contains vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings Sawmills and Wood Preservation Plants Industry (U

WASHINGTON, Nov. 5, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today a

Evolent Health, Inc.'s (EVH) CEO Seth Blackley on Q3 2021 Results - Earnings Call Transcript